ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
3
views
0
references
Top references
cited by
1
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
2,757
similar
All similar
Record
: found
Abstract
: not found
Book
: not found
Current. A Phase I/II study of regorafenib plus avelumab in solid tumors (REGOMUNE)
Author(s):
Publication date:
2018
Read this book at
Bookmark
There is no author summary for this book yet. Authors can add summaries to their books on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Paul Drude Institute for Solid State Electronics (PDI)
Data availability:
Comments
Comment on this book
Sign in to comment
Similar content
2,757
Regorafenib, the CORRECT way forward or just another GRIDlock?
Authors:
Cristina Villanueva
Gastrointestinal cancer: regorafenib, the CORRECT way forward or just another GRIDlock?
Authors:
M Teresa Villanueva
Avelumab (MSB0010718C; anti-PD-L1) as a first-line treatment for patients with advanced NSCLC from the JAVELIN Solid Tumor phase 1b trial: safety, clinical activity, and PD-L1 expression
Authors:
CF Verschraegen
,
F Chen
,
DR Spigel
…
See all similar
Cited by
1
Combination Antiangiogenic and Immunotherapy for Advanced Hepatocellular Carcinoma: Evidence to Date
Authors:
Alison L. Raybould
,
Hanna Sanoff
See all cited by